PRED'IC: an objective "second opinion" to ensure the safe return home of your heart failure patients
Designed to integrate seamlessly into your computerized patient record, PRED'IC requires no additional input from you.
Thanks to an exceptional Negative Predictive Value (>97%) , the algorithm allows you to exclude the risk of rehospitalization at 90 days with unprecedented reliability, limiting over-triage thanks to a specificity of 70% (compared to 36% for human assessment alone) .
By providing you with a transparent and explainable risk score, PRED'IC reduces your cognitive load and helps you focus your valuable resources (remote monitoring, IPA) on high-risk patients, while leaving you in absolute control of the medical decision.
_edited.jpg)
PRED'IC is a digital medical device (SAMD) designed to personalize post-hospitalization monitoring of heart failure patients. Clinically validated, it uses hospital data to stratify risk, anticipate decompensations, and optimize care pathways .
Compliant with Regulation (EU) 2017/745 (MDR), and developed according to current quality and security standards, PREDIC is deployed in an on-premises environment, guaranteeing a high level of cybersecurity and data control . Its ethical design ensures transparency of algorithms and compliance with the GDPR. For medical teams, it is a reliable decision-support tool integrated into their workflow ; for management, it is a lever for efficiency , with an expected medico-economic impact on length of stay and avoidable costs.
PRED'IC was developed and validated by KanopyMed in collaboration with the University Hospital of Montpellier . Its performance was validated by a multicenter clinical study .
Integration into the workflow of professionals and usability are at the heart of the tool, co-created with healthcare professionals from different backgrounds.
